Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Lancet. Neurology|April 14, 2023
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional studyAndrew Siderowf, Luis Concha-Marambio, David-Erick Lafontant, et al.The Lancet. Neurology|January 24, 2024
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for researchTanya Simuni, Lana M Chahine, Kathleen Poston, et al.NPJ Parkinson'S Disease|September 27, 2024
Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohortsTien Dam, Gennaro Pagano, Michael C Brumm, et al.Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohortsTien Dam, Gennaro Pagano, Michael C Brumm, et al.Science Translational Medicine|August 17, 2018
Finding useful biomarkers for Parkinson's diseaseAlice S Chen-Plotkin, Roger Albin, Roy Alcalay, et al.Digital Biomarkers|January 14, 2021
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory ScienceDiane Stephenson, Robert Alexander, Varun Aggarwal, et al.The Lancet. Neurology|August 15, 2015
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyMike A Nalls, Cory Y McLean, Jacqueline Rick, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 2020
Differences in the Presentation and Progression of Parkinson's Disease by SexHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.Nature Medicine|July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Rowan Saloner, Jacob W Vogel, et al.Pageof 4